Risk estimation for a malignant transformation of oral lesions by S100A7 and Doc-1 gene expression

Cancer Investigation

Volumn 29, Issue 7, 2011, Pages 478-484

  Winter, Jochen ^a   Pantelis, Annette ^a   Reich, Rudolf ^a   Jepsen, Soeren ^a   Allam, Jean Piere ^a   Novak, Natalija ^a   Wenghoefer, Matthias ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Cancer; Doc 1; Intraoral squamous cell carcinoma; S100A7

Indexed keywords

BETA ACTIN; DOC 1 PROTEIN; PSORIASIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; FEMALE; FIBROMA; GENE EXPRESSION; GENE INACTIVATION; GENE OVEREXPRESSION; GINGIVA; HUMAN; HUMAN TISSUE; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MARKER GENE; MOUTH CARCINOMA; MOUTH LESION; PRIORITY JOURNAL; RNA EXTRACTION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FIBROMA; HUMANS; LEUKOPLAKIA, ORAL; MALE; MOUTH NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK; S100 PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 79960175719     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2011.597813     Document Type: Article

References (42)

1. Silverman S, Jr. Oral Cancer, 4th edition. Hamilton, BC: Decker, 1998; 25-33.
2. Chambers MS, Jacob RF.How carcinogens cause cancer. TexDent J 1994;111:13-19.
3. Wenghoefer M, Pesch B,Harth V, Broede P, Fronhoffs S, LandtO, Brouning T, Abel J, Bolt HM, Herberhold C, Vetter H, Ko YD. Association between head and neck cancer and microsomal epoxide hydrolase genotypes. Arch Toxicol 2003;77(1):37-41. (Pubitemid 36056981)
4. Pindborg JJ. Oral Cancer and Precancer. Bristol: JohnWright and Sons, 1980.
5. Shintani S, Mihara M, Nakahara Y, Kiyota A, Ueyama Y, Matsumura T,Wong DT. Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. Oral Oncol 2002;38(3):235-243. (Pubitemid 34442544)
6. Bouquot JE. Epidemiology. In Pathology of the Head and Neck, DG Gnepp (eds.). New York, NY: Churchill Livingstone, 1987, 263-314.
7. Bouquot JE. Reviewing oral leukoplakia-clinical concepts for the 1990s. J Amer Dent Assoc 1991;122:80-82.
8. Wenghoefer M, Pantelis A, Dommisch H, Reich R, Martini M, Allam JP, Novak N, Berǵe S, Jepsen S, Winter J. Decreased gene expression of human beta-defensin-1 in the development of squamous cell carcinoma of the oral cavity. Int J Oral Maxillofac Surg 2008a;37(7):660-663. (Pubitemid 351905974)
9. SEER. Surveillance, Epidemiology, and End Results-Brochure. (Program of the National Cancer Institute, United States of America, www.cancer.gov, 2005.
10. Axell, T. A prevalence study of oral mucosal lesions in an adult Swedish population. Odont Revy 1976;27(suppl. 26):1-103.
11. Bouquot JE, Gundlach KKH. Oral exophytic lesions in 23,616 white Americans over 35 years of age. Oral Surg Oral Med Oral Pathol 1986;62:284-291.
12. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007;36(10):575-580. (Pubitemid 47609807)
13. Sciubba JJ. Oral leukoplakia. Crit Rev Oral Biol Med 1995;6(2):147-160.
14. WenghoeferM, PantelisA,Najafi T, Deschner J, AllamJP, Novak N, Reich RH, Martini M, Berǵe S, Jepsen S, Winter J. Gene expression of oncogenes, antimicrobial peptides and cytokines in the development of oral leukoplakia. Oral Surg OralMed Oral Pathol Oral Radiol Endod 2010;110(3):351-356.
15. Winter J, Pantelis A, Allam JP, Novak N, Reich R, Martini M, Berg?e S, Deschner J, Jepsen S, Wenghoefer M. High α-defensin and S100A7 expression and missingDOC-1 downregulation characterize irritation fibromas of the oral cavity andmight counteract malignant transformation. J Craniofac Surg 2011;22(1):100-104.
16. Dayan D, Bodner L, Hammel I, Wolman M. Histochemical characterization of collagen fibers in fibrous overgrowth (irritation fibroma) of the oral mucosa: effect of age and duration of lesion. Arch Gerontol Geriatr 1994;18(1):53-57. (Pubitemid 24087064)
17. Kim ST, Kim HJ, Park IS, Park SW, Kim WH, Kim YM. Chronic, reactive conditions of the oral cavity simulatingmucosal carcinomas: CT and MR imaging findings with pathologic correlation in five patients. Clin Imaging 2005;29(6):406-411. (Pubitemid 41597078)
18. Matsuo K, Shintani S, Tsuji T, Nagata E, Lerman M, McBride. p12DOC-1, a growth suppressor, associateswithDNApolymerase a/primase. FASEB J 2000;14:1318-1324.
19. Shintani S, Ohyama H, Zhang X, McBride J, Matsuo K, Tsuji T. p12DOC-1 is a novel CDK2-associated protein. Mol Cell Biol 2001a;20:6300-6307.
20. Todd R, McBride J, Tsuji T, Donoff RB, Nagai M, Chou MY. Deleted in oral cancer-1 (doc-1), a novel oral tumor suppressor gene. FASEB J 1995;9:1362-1370.
21. Tsuji T, Duh FM, Latif F, Popescu NC, Zimonjic DB, McBride J. Cloning, mapping, expression, function, and mutation analyses of the human ortholog of the hamster putative tumor suppressor gene doc-1. J Biol Chem 1998;273:6704-6709. (Pubitemid 28160329)
22. Shintani S, Mihara M, Terakado N, Nakahara Y, Matsumura T, Kohno Y, Ohyama H, McBride J, Kent R, Todd R, Tsuji T, Wong DT. Reduction of p12DOC-1 expression is a negative prognostic indicator in head and neck/oral cancer. Clin Cancer Res 2001b;7:2776-2782. (Pubitemid 32911384)
23. Santamaria-Kisiel L, Rintala-Dempsey AC, Shaw GS. Calciumdependent and -independent interactions of the S100 protein family. Biochem J 2006;396:201-214. (Pubitemid 43837235)
24. Mueller A, Schafer BW, Ferrari S, Weibel M, Makek M. The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J Biol Chem 2005;280:29186-29193. (Pubitemid 41161370)
25. Watson PH, Leygue ER, Murphy LC. Psoriasin (S100A7). Int J Biochem Cell Biol 1998;30:567-571.
26. Emberley ED, Murphy LC,Watson PH. S100A7 and the progression of breast cancer. Breast Cancer Res 2004;6:153-159. (Pubitemid 39136481)
27. Heizmann CW, Fritz G, Schafer BW. S100 proteins: structure, functions and pathology. Front Biosci 2002;7: d1356-1368.
28. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003;60:540-551.
29. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001;33:637-668. (Pubitemid 32520962)
30. Eckert RL, Broome AM, RuseM, Robinson N, Ryan D, et al. S100 proteins in the epidermis. J Invest Dermatol 2004;123:23-33. (Pubitemid 38833459)
31. Madsen P, Rasmussen HH, Leffers H, Honore B, Dejgaard K. Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin", that is highly up-regulated in psoriatic skin. J Invest Dermatol 1991;97:701-712.
32. Broome AM, RyanD, Eckert RL. S100 protein subcellular localization during epidermal differentiation and psoriasis. J Histochem Cytochem 2003;51:675-685. (Pubitemid 36520623)
33. El-Rifai W, Moskaluk CA, Abdrabbo MK, Harper J, Yoshida C. Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res 2002;62:6823-6826. (Pubitemid 35424067)
34. Zhang H, Zhao Q, Chen Y, Wang Y, Gao S, et al. (2008) Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas.Thorax 63:352-359. (Pubitemid 351497949)
35. Moubayed N, Weichenthal M, Harder J, Wandel E, Sticherling M. Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. J Cancer Res Clin Oncol 2007;133: 253-261.
36. Ji J, Zhao L, Wang X, Zhou C, Ding F. Differential expression of S100 gene family in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2004;130:480-486. (Pubitemid 39119292)
37. Celis JE, Rasmussen HH, Vorum H, Madsen P, Honore B, et al. Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J Urol 1996;155:2105-2112. (Pubitemid 26146716)
38. Al-Haddad S, Zhang Z, Leygue E, Snell L, Huang A, et al. Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol 1999;155:2057-2066.
39. Tripathi SC, Matta A, Kaur J, Grigull J, Chauhan SS, Thakar A, Shukla NK, Duggal R, DattaGupta S, Ralhan R, Siu KW. Nuclear S100A7 is associatedwith poor prognosis in head and neck cancer. PLoS One 2010;5(8):e11939.
40. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:2002-2007.
41. Pantelis A, Wenghoefer M, Haas S, Merkelbach-Bruse S, Pantelis D, Jepsen S, Bootz F, Winter J. Down regulation and nuclear localization of human beta-defensin-1 in pleomorphic adenomas of salivary glands. Oral Oncol 2008.
42. Kesting MR, Loeffelbein DJ,Hasler RJ,Wolff KD, Rittig A, Schulte M, Hirsch T, Wagenpfeil S, Jacobsen F, Steinstraesser L. Expression profile of human beta-defensin 3 in oral squamous cell carcinoma. Cancer Invest 2009;27(5):575-581.